trademan1

CYCC Oversold Previously, Now Everyone's Buying

Pembelian
NASDAQ:CYCC   Cyclacel Pharmaceuticals, Inc.
It gapped down in the past because they dropped one of their studies but the company has many other products in development. There are messages that the float has been bought up and funds and insiders are buying heavily for some event.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.